Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ·Healthcare·Biotechnology
$4.11
+0.98%
Mkt Cap $263.69M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$13.00
Range $13.00 – $13.00
Implied Upside
+216.3%
Consensus $13.00 vs current $4.11